https://www.bioworld.com/rss en-us A precision medicine diagnostic system developed by Diag-Nose Medical Pty. Ltd. could potentially transform the management of chronic respiratory diseases. Co-founders Eldin Rostrom, David Yen, Brian Wang and Josie Xu set out to explore why patients with similar respiratory symptoms respond so differently to treatment. http://www.bioworld.com/articles/726383 Mon, 24 Nov 2025 11:00:00 -0500 https://www.bioworld.com/articles/726383-diag-noseio-develops-respiratory-disease-precision-diagnostics Diag.nose.ai Diag-Nose.io’s nasal Abel microsampler. Credit: Diag-Nose Medical Pty. Ltd. Withings SA received U.S. FDA clearance for Beamo, its health check-up tool designed to monitor heart and lung function. Described as the ‘thermometer of the future’, Beamo combines the sensors of an electrocardiogram, a stethoscope and a thermometer into a hand-held device to allow users to check their body temperature, cardiac and pulmonary health in less than a minute. http://www.bioworld.com/articles/725992 Fri, 14 Nov 2025 11:00:00 -0500 https://www.bioworld.com/articles/725992-fda-clears-withings-beamo-thermometer-of-the-future Withings Beamo multi-sensor device Withings Beamo multi-sensor device. Credit: Withings France SA Mode Sensors AS received U.S. FDA 510(k) clearance for its Re:Balans hydration monitoring system. The wearable patch sensor allows for the continuous monitoring of body hydration to detect fluid imbalances using thoracic bioimpedance technology to deliver automatic, accurate data to help physicians in fluid management. http://www.bioworld.com/articles/725174 Fri, 24 Oct 2025 12:00:00 -0400 https://www.bioworld.com/articles/725174-mode-sensors-hydration-monitoring-system-receives-fda-clearance ReBalans hydration monitoring patch ReBalans hydration monitoring patch. Credit: Mode Sensors Oura Health Oy raised more than $900 million in a series E funding round to fuel global expansion of its popular smart ring and development of new health technologies. The new infusion brings the company’s total funds raised to date to $1.5 billion and implies a corporate valuation of about $11 billion, Oura said. http://www.bioworld.com/articles/724916 Tue, 14 Oct 2025 12:00:00 -0400 https://www.bioworld.com/articles/724916-oura-rings-in-900m-fundraising-round-for-global-expansion Oura Ring Oura ring. Credit: Oura Health Oy Researchers at Heriot-Watt University received more than £475,000 ($637,000) in funding to advance clinical work on a vibroacoustic sensor which could change how eczema is diagnosed and treated. http://www.bioworld.com/articles/724499 Fri, 03 Oct 2025 12:00:00 -0400 https://www.bioworld.com/articles/724499-uk-researchers-secure-funding-for-eczema-skin-sensor Tissuemetrics device for eczema diagnosis Tissuemetrics device for eczema diagnosis. Credit: Heriot-Watt University Researchers from the University of California, Davis (UC-Davis) continue to assemble intellectual property in support of their development of methods and techniques which improve the accuracy of wearable sensor technologies. http://www.bioworld.com/articles/723457 Fri, 29 Aug 2025 12:00:00 -0400 https://www.bioworld.com/articles/723457-storx-sensors-monitor-fetal-health-during-labor-and-delivery Storx Sensors WO2025171056-A1, “Deep harmonic finesse: signal separation in wearable systems with limited data.”Assignee: The Regents of The University of California}Inventors: Ghiasi, Soheil; Saffarpour, MahyaIPC codes: G06F 18/2134; A61B 5/00; G06N 3/02Publication date: Aug. 14, 2025Earliest priority details: US2024550021, Feb. 24, 2024 Rhovica Neuroimaging AG raised CHF 2.3 million (US$2.85 million) in a pre-seed financing round for Sonav, its bedside navigation system designed for extraventricular drainage. With its integrated sensors that provide real-time visualization to guide catheter insertion into brain ventricles, Sonav has the potential to transform emergency neurosurgery by improving safety and precision. http://www.bioworld.com/articles/723429 Tue, 26 Aug 2025 12:00:00 -0400 https://www.bioworld.com/articles/723429-rhovica-raises-chf23m-for-external-ventricular-drainage-system Illustration of brain and brain waves, concept of focal seizure Trinity Biotech plc recently unveiled CGM+, an AI-native, wearable biosensor that goes beyond traditional continuous glucose monitors and tracks glucose levels, cardiovascular activity and body temperature at the same time. The company believes that as precision medicine becomes central to health care, especially with the collection of real-time data, CGM+ will become a critical enabler of AI-based diagnostics, behavioral coaching and chronic disease management. http://www.bioworld.com/articles/722533 Mon, 28 Jul 2025 12:00:00 -0400 https://www.bioworld.com/articles/722533-trinity-unveils-ai-powered-cgm-biosensor Trinity CGM+ Trinity CGM+. Credit: Trinity Biotech Researchers from IMEC, the Netherlands’ OnePlanet Research Center in Wageningen, filed for protection of an inexpensive, highly miniaturized ingestible device that may be used for remotely activatable sampling, gut health monitoring and drug delivery. http://www.bioworld.com/articles/721804 Wed, 09 Jul 2025 12:00:00 -0400 https://www.bioworld.com/articles/721804-imec-seeks-ingestible-gi-sensor-patent IMEC ingestible GI sensor US20250195045-A1, “Ingestible device and method for sampling material using a gas generating actuator.”Assignee: Stichting Imec NederlandInventors: Schoeman, Rogier; Elias, Jinane; De Wit, Jan WillemIPC codes: A61B 10/00Publication date: June 19, 2025Earliest priority details: EP2023218100, Dec. 19, 2023 Glucomodicum Oy reported positive results from a clinical study in which its needle-free continuous glucose monitor, Talisman, was tested in participants across both standard multi-hour glucose tolerance and ambulatory conditions involving exercise and meals. http://www.bioworld.com/articles/721796 Tue, 08 Jul 2025 12:00:00 -0400 https://www.bioworld.com/articles/721796-glucomodicum-reports-positive-data-from-its-needle-free-cgm Glucomodicum-CGM-8july25.jpg Glucomodicum Talisman. Credit: Glucomodicum Health care technology company Wearoptimo Ltd. developed a next-generation microwearable sensor that accurately detects hydration levels, outperforming the needle-based gold standard. http://www.bioworld.com/articles/719517 Tue, 29 Apr 2025 12:00:00 -0400 https://www.bioworld.com/articles/719517-wearoptimos-hydration-sensor-outperforms-gold-standard-tests Wearoptimo microwearable hydration sensor Wearoptimo microwearable hydration sensor. Credit: Wearoptimo Seung-min Park, professor at Nanyang Technological University and cofounder of Kanaria Health, is working to manufacture smart bidets that can capture biomarker data from urine and stool automatically and enable continuous monitoring. http://www.bioworld.com/articles/717994 Thu, 20 Mar 2025 11:00:00 -0400 https://www.bioworld.com/articles/717994-toilets-could-be-the-next-big-health-device-medical-korea-2025 The U.S. FDA’s latest draft guidance on pulse oximeters drew comment from the International Standards Organization and the International Electrotechnical Commission, which are making the case that in addition to differences in pigmentation, the pulsatility of the tissue in contact with the device is also a factor in device performance. http://www.bioworld.com/articles/717890 Wed, 12 Mar 2025 11:00:00 -0400 https://www.bioworld.com/articles/717890-iso-iec-advise-against-simplistic-approaches-to-pulse-ox-performance Hospital patient wearing pulse oximeter Researchers from The George Washington University and Northwestern University filed for protection of a bioresorbable, transparent, microelectrode array (MEA) technology that they believe offers unique advantages. http://www.bioworld.com/articles/715952 Fri, 10 Jan 2025 11:00:00 -0500 https://www.bioworld.com/articles/715952-bioresorbable-microelectrode-array-implant-for-cardiac-conditions soft microelectrode WO2025007130-A2, “Soft, bioresorbable, transparent microelectrode array for cardiac applications.”Assignee: The George Washington UniversityInventors: Lu, Luyao; Efimov, Igor R.IPC Codes: A61N 5/06Publication date: Jan. 2, 2025Earliest priority details: US2023524485, June 30, 2023 Dexcom Inc. put real money behind expanding its integration efforts, with a $75 million investment in the $200 million series D for Ōura Health Oy, the maker of the Ōura smart ring. Ōura and Dexcom also provided details on a strategic partnership that integrates data from Dexcom’s continuous glucose monitors with vital sign, sleep, stress, heart health and activity data from the Ōura ring. http://www.bioworld.com/articles/715224 Thu, 19 Dec 2024 11:00:00 -0500 https://www.bioworld.com/articles/715224-ura-closes-200m-series-d-dexcom-invests-75m Oura Ring Oura ring. Credit: Oura Health Oy U.K. researchers at Nottingham Trent University, the University of Southampton and University Hospital Southampton and product development company Zelemiq Ltd. developed a wearable sensor that accurately monitors and detects changes in people’s breathing without requiring direct contact with the skin. http://www.bioworld.com/articles/715108 Thu, 12 Dec 2024 11:00:00 -0500 https://www.bioworld.com/articles/715108-uk-researchers-develop-pneumorator-a-wearable-respiratory-sensor Pneumorator The Pneumorator wireless, contactless respiratory sensor. Europlaz Technologies Ltd. has developed a new neonatal flow sensor that could help improve neonatal care and save the lives of babies born prematurely. The company created an integrated ‘sidestream’ carbon dioxide (CO2) sampling port, which when added to the side of its existing neonatal flow sensor will enable clinicians to monitor CO2 being exhaled from the baby’s lungs to better inform care. http://www.bioworld.com/articles/715100 Wed, 11 Dec 2024 11:00:00 -0500 https://www.bioworld.com/articles/715100-europlaz-develops-neonatal-device-to-save-babies-lives Europlaz neonatal flow sensor Europlaz neonatal flow sensor. Credit: Europlaz Technologies Ltd. Researchers developed a novel electrochemical biosensor technology capable of assessing symmetric dimethylarginine to detect early kidney disease, which could be adapted to detect other biomarkers for conditions like cancer. http://www.bioworld.com/articles/714296 Fri, 22 Nov 2024 11:00:00 -0500 https://www.bioworld.com/articles/714296-researchers-develop-first-sdma-based-biosensor-for-kidney-disease SDMA kidney Researchers from North Carolina State University filed for protection of miniaturized, wireless, wound-monitoring sensors that may be incorporated into swabs or wound dressings for real-time, accurate assessment of wound status. http://www.bioworld.com/articles/714264 Tue, 19 Nov 2024 11:00:00 -0500 https://www.bioworld.com/articles/714264-nc-state-researchers-file-patent-for-wound-monitoring-sensors wound monitoring US20240366146-A1, “Swab-integrated multi-analyte sensors for wound monitoring.”Assignee: North Carolina State UniversityInventors: Bandodkar, Amay; Kim, Yong JaeIPC codes: A61B 5/103; A61B 5/00Publication date: Nov. 7, 2024Earliest priority details: US2023464378, May 5, 2023 Smartcardia SA received U.S. FDA clearance for mobile outpatient cardiac telemetry for its seven-lead live ECG monitoring patch and cloud platform. With the approval, the solution can now be used for remote live monitoring of a patient’s ECG and immediately notify clinicians in cases of arrhythmias. http://www.bioworld.com/articles/714257 Mon, 18 Nov 2024 11:00:00 -0500 https://www.bioworld.com/articles/714257-smartcardias-ecg-patch-gains-fda-nod-for-outpatient-cardiac-telemetry Heart, DNA and ECG A team of researchers from the University of Northumbria filed for protection of a flexible transdermal patch taht uses surface acoustic wave technology they believe offers distinct advantages over traditional transdermal patches. http://www.bioworld.com/articles/710423 Tue, 23 Jul 2024 12:00:00 -0400 https://www.bioworld.com/articles/710423-wearable-acoustic-patch-developed-for-transdermal-drug-delivery transdermal patch WO2024126989-A1, “Patch.”Assignee: University of Northumbria at NewcastleInventors: Arnold, Peter; Fu, Richard; Torun, HamdiIPC Codes: A61N 7/00; A61M 5/142; A61M 37/00Publication Date: June 20, 2024Earliest priority details: GB202218636, Dec. 12, 2022 In what represents the first PCT filing to be published in the name of Bayreuth, Germany-headquartered Incontalert GmbH, the company’s co-founders seek protection for a wearable device which employs machine learning techniques to non-invasively predict the bladder filling level for incontinence patients. http://www.bioworld.com/articles/708860 Wed, 22 May 2024 12:00:00 -0400 https://www.bioworld.com/articles/708860-incontalert-wearable-sensor-for-predicting-bladder-fluid-retention bladder-filling-level-22may24.jpg WO2024083885-A1, “Device for determining bladder filling level of the urinary bladder of a user in a non-invasive manner and method therefore.”Assignee: Incontalert GmbHInventors: Fechner, Pascal; Lockl, Jannik; Ruhland, Nicolas; Zürl, TristanIPC Codes: A61B 5/00; A61B 5/20; A61B 5/0536Publication date: April 25, 2024 (also published as EP4356819-A1, April 24, 2024)Earliest priority details: EP2022202749, Oct. 20, 2022 Wubin Bai, assistant professor of applied physical sciences at UNC-Chapel Hill, is seeking protection for morphable 3D-folded microelectronic mesostructures, including epicardial bioelectronic probes, made using concepts borrowed from origami. http://www.bioworld.com/articles/708284 Fri, 17 May 2024 12:00:00 -0400 https://www.bioworld.com/articles/708284-researchers-develop-origami-like-device-for-heart-monitoring oragami-heart-monitor WO2024086654-A1, “Apparatuses, methods, and systems for reconfigurable three-dimensional mesostructures.”Assignee: The University Of North Carolina At Chapel HillInventors: Bai, Wubin; Zhang, LinIPC Codes: A61B 5/283; A61B 5/00Publication date: April 24, 2024Earliest priority details: US2022380355, Oct. 20, 2022 holland.johnson@clarivate.com Apple Inc. said the U.S. FDA has approved the Apple Watch's atrial fibrillation (AF) history feature under its rigorous Medical Device Development Tools (MDDT) program that specifies what devices health professionals can rely on. http://www.bioworld.com/articles/707944 Fri, 03 May 2024 12:00:00 -0400 https://www.bioworld.com/articles/707944-fda-qualifies-apple-atrial-fibrillation-history-feature-as-an-mddt Apple Computer Inc. logo In what represents its first patenting, PBSF Inc. filed for protection of brain monitoring and neuroprotection strategies for infants at high risk on a large scale. http://www.bioworld.com/articles/707914 Tue, 30 Apr 2024 12:00:00 -0400 https://www.bioworld.com/articles/707914-patent-filed-for-ai-use-in-early-detection-of-neonatal-brain-injuries ai-tbi WO2024074874-A1, “Time-series anomaly detection for health care.”Assignee: PBSF Inc.Inventors: Variane, GabrielIPC Codes: G16H 50/20; G16H 50/50; A61B 5/00Publication date: April 11, 2024Earliest priority details: WO2022IB59579, Oct. 6, 2024 Less than two years after acquiring Sound United for $1.025 billion, Masimo Corp. plans to hive off the consumer audio subsidiary along with consumer health products such as its Stork baby monitor and Freedom smart watch and band. The “rushed” announcement made Friday “came after being informed that Politan intended to nominate directors this week,” said activist investor Politan Capital Management. Politan, which owns 8.9% of the company, secured two board seats in a highly contentious proxy battle last year and nominated two more on Monday morning. http://www.bioworld.com/articles/706781 Mon, 25 Mar 2024 12:00:00 -0400 https://www.bioworld.com/articles/706781-sound-decision-masimo-to-split-off-consumer-business Masimo Ultrahuman Healthcare Private Ltd. recently raised $35 million in a series B investment round to accelerate the company’s growth. Ultrahuman has developed several products, most notably a smart ring, which measures a range of physiological signals to impact health and wellbeing. http://www.bioworld.com/articles/706779 Mon, 25 Mar 2024 12:00:00 -0400 https://www.bioworld.com/articles/706779-ultrahuman-raises-35m-to-accelerate-growth Ultrahuman Ring The latest filing from Orlando-based Noble International Inc.—an Aptar Pharma company—hints at the development of a new category of medical devices. Best known for its medical device training solutions and patient onboarding strategies, Noble filed for protection of a compression sleeve for monitoring and treating rheumatic disorders. http://www.bioworld.com/articles/706458 Thu, 21 Mar 2024 12:00:00 -0400 https://www.bioworld.com/articles/706458-noble-international-develops-compression-sleeve-for-rheumatoid-arthritis Nobel compression sleeve WO2024039844-A1, “Compression sleeve for quantitative measurements.”Assignee: Noble International IncInventors: Cardoza, Randy; Lettman, Jeffery, A.; Miller, JeffIPC Codes: A61B 90/00; A61N 5/06; A61B 5/00Publication date: Feb. 22, 2024Earliest priority details: US2022399062, Aug. 18, 2022 Roche AG debuted a new continuous glucose monitor (CGM) at the Advanced Technologies & Treatments for Diabetes conference in Florence, Italy, last week, but how appealing users will find it remains unclear – as is the market opportunity given the entrenched position of Abbott Laboratories and Dexcom Inc. http://www.bioworld.com/articles/706224 Mon, 11 Mar 2024 12:00:00 -0400 https://www.bioworld.com/articles/706224-roche-introduces-new-glucose-monitor-but-why Roche Accu-Check CGM Roche Accu-Check Smartguide CGM. Credit: Roche The U.K. government said it will take action to tackle potential bias in the design and use of medical devices after an independent review found that there is extensive evidence of poorer performance of certain technologies, like pulse oximeters, in patients with darker skin tones. http://www.bioworld.com/articles/706223 Mon, 11 Mar 2024 12:00:00 -0400 https://www.bioworld.com/articles/706223-uk-to-take-action-to-tackle-bias-in-medical-devices Hospital patient wearing pulse oximeter